FAQs About the Longitude Prize on ALS What is the Longitude Prize on ALS?

What is the Longitude Prize on ALS?

The Longitude Prize on ALS is a £7.5m GBP [~$10m USD] international programme that seeks to incentivise the use of AI-based approaches to transform therapeutic discovery for the treatment of amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND). 


The Longitude Prize for ALS is the third modern Longitude Prize, after the Longitude Prize on Antimicrobial Resistance (AMR) (awarded in June 2024) and the current Longitude Prize on Dementia.

Go back to: About the Longitude Prize on ALS